Related Experiment Video
Updated: May 4, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
12.4K
Myeloproliferative neoplasms in five multiple sclerosis patients.
Sigrun Thorsteinsdottir1, Ole Weis Bjerrum2, Hans Carl Hasselbalch1
1Department of Hematology, Roskilde Hospital, University of Copenhagen, Denmark.
Leukemia Research Reports
|December 28, 2013
Summary
The rare co-occurrence of myeloproliferative neoplasms (MPNs) and multiple sclerosis (MS) was observed in five patients from Denmark. This suggests potential shared environmental or genetic factors may link these distinct conditions.
Area of Science:
- Hematology
- Neurology
- Epidemiology
Background:
- Myeloproliferative neoplasms (MPNs) and multiple sclerosis (MS) are distinct conditions.
- The simultaneous occurrence of MPNs and MS is considered unusual in medical literature.
Purpose of the Study:
- To report and describe five cases of patients diagnosed with both MPNs and MS.
- To investigate a potential link between MPNs and MS, particularly within a specific geographic region.
Main Methods:
- Case series reporting of five patients with concurrent MPNs and MS.
- Review of patient histories and treatment records.
- Geographic localization of cases within Denmark.
Main Results:
- Five patients from a localized area in Denmark were diagnosed with both MPNs and MS between 2007-2012.
- Detailed patient histories and treatment outcomes were documented.
- No previous recognition of a link between MS and MPNs was found.
Conclusions:
- The observed concurrence of MPNs and MS in this cohort warrants further investigation.
- Potential shared environmental factors may contribute to the development of both MPNs and MS.
- Unrecognized genetic predispositions could also play a role in patients developing both conditions.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
01:15Differentiation of Common Myeloid Progenitor Cells
3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
01:19Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K